Jackson (JXN) Faces a Minor Decline Amid Broader Market Movements
Jackson Financial Inc., a U.S.‑based provider of retirement planning and annuity products, experienced a modest 0.21 % decline in its share price during a 24‑hour trading window that concluded at 10:19 AM Central European Time on Thursday, 22 November 2026. At the close, one share of Jackson was priced at approximately USD 130.17 on major exchanges.
Market Context
The company’s shares are actively traded, with roughly USD 93.8 million exchanged in the last 24 hours against a total outstanding supply of 67.7 million shares. This level of liquidity keeps the market capitalization close to USD 8.8 billion. Over the past month, Jackson’s stock has risen 0.46 %, reflecting a modest upward trend relative to the broader market.
Key technical indicators provide additional perspective:
- 200‑Day Simple Moving Average (SMA): USD 117.42
- 52‑Week High: USD 140.90 (reached on 11 September 2026)
- 52‑Week Low: USD 89.67 (last seen on 18 November 2025)
These metrics suggest that, while the stock has dipped slightly in the short term, it remains above its long‑term average and well above its recent lows, indicating resilience in the face of short‑term volatility.
Comparative Performance of Peer Stocks
Jackson’s recent performance can be better understood against the backdrop of related equities:
| Stock | 24‑Hour Movement | Current Price | Market Cap (USD bn) | P/E Ratio |
|---|---|---|---|---|
| Clorox (CLX) | –3.06 % | USD 84.77 | 10.3 | 18.18 |
| Knight‑Swift Transportation (KNX) | –0.08 % | USD 63.20 | 10.3 | 239.6 |
| Regal Rexnord (RRX) | +1.76 % | USD 158.78 | 10.4 | 32.04 |
| Jefferies (JEF) | +0.04 % | USD 45.03 | 10.3 | 11.87 |
| Oscar Health (OSCR) | –0.62 % | USD 33.45 | 10.4 | 17.82 |
Jackson’s slight decline contrasts with the modest gains seen at Regal Rexnord and Jefferies, while mirroring the broader downward trend observed at Clorox and Oscar Health. Knight‑Swift Transportation remains largely flat, underscoring the relative stability of the sector.
Outlook for Oscar Health
Oscar Health, a peer listed above, is slated to release its quarterly results on 5 November 2026, covering the period ending 30 September 2026. Analysts project the company will report a modest per‑share loss—an improvement from the larger loss reported in the same quarter the previous year—while revenues are expected to surge by roughly 57 % year‑over‑year, targeting sales near USD 4.5 billion. For the full fiscal year, consensus estimates forecast a turnaround to a small profit per share and a revenue increase exceeding 50 %. These forthcoming figures will likely influence market sentiment for the entire sector, including Jackson.
Summary
Jackson Financial Inc. remains a well‑capitalized, liquidly traded entity with a solid long‑term technical profile. Its recent 0.21 % dip is modest and within the context of a market that has seen mixed movements across comparable stocks. Investors will be watching the upcoming earnings releases—particularly from Oscar Health—as they may offer insight into broader trends in the financial services and health‑tech sectors.
